Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease

Sridevi Devaraj, Rong Tang, Beverley A Huet, Andrea Harris, Thanalakshmi Seenivasan, James A de Lemos, Ishwarlal Jialal

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Background: Oxidative stress and inflammation are crucial in atherogenesis. α-Tocopherol is both an antioxidant and an antiinflammatory agent. Objective: We evaluated the effect of RRR-α-tocopherol supplementation on carotid atherosclerosis in patients with stable coronary artery disease (CAD) on drug therapy. Design: Randomized, controlled, double-blind trial compared RRR-α-tocopherol (1200 IU/d for 2 y) with placebo in 90 patients with CAD. Intimal medial thickness (IMT) of both carotid arteries was measured by high-resolution B-mode ultrasonography at 0, 1, 1.5, and 2 y. At 6-mo intervals, plasma α-tocopherol concentrations, C-reactive protein (CRP), LDL oxidation, monocyte function (superoxide anion release, cytokine release, and adhesion to endothelium), and urinary F2-isoprostanes were measured. Results: α-Tocopherol concentrations were significantly higher in the α-tocopherol group but not in the placebo group. High-sensitivity CRP concentrations were significantly lowered with α-tocopherol supplementation than with placebo (32%; P < 0.001). α-Tocopherol supplementation significantly reduced urinary F2-isoprostanes (P < 0.001) and monocyte superoxide anion and tumor necrosis factor release compared with baseline and placebo (P < 0.001). No significant difference was observed in the mean change in total carotid IMT in the placebo and α-tocopherol groups. In addition, no significant difference in cardiovascular events was observed (P = 0.21). Conclusions: High-dose RRR-α-tocopherol supplementation in patients with CAD was safe and significantly reduced plasma biomarkers of oxidative stress and inflammation but had no significant effect on carotid IMT during 2 y.

Original languageEnglish (US)
Pages (from-to)1392-1398
Number of pages7
JournalAmerican Journal of Clinical Nutrition
Volume86
Issue number5
StatePublished - Nov 1 2007

Fingerprint

Carotid Artery Diseases
Tocopherols
atherosclerosis
tocopherols
Coronary Artery Disease
biomarkers
Oxidative Stress
oxidative stress
inflammation
Biomarkers
Inflammation
dosage
placebos
Tunica Intima
Placebos
F2-Isoprostanes
C-reactive protein
Superoxides
superoxide anion
monocytes

Keywords

  • Atherosclerosis
  • Carotid
  • Coronary artery disease
  • Inflammation
  • Intimal media thickness
  • Oxidative stress
  • Vitamin E

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. / Devaraj, Sridevi; Tang, Rong; Huet, Beverley A; Harris, Andrea; Seenivasan, Thanalakshmi; de Lemos, James A; Jialal, Ishwarlal.

In: American Journal of Clinical Nutrition, Vol. 86, No. 5, 01.11.2007, p. 1392-1398.

Research output: Contribution to journalArticle

Devaraj, Sridevi ; Tang, Rong ; Huet, Beverley A ; Harris, Andrea ; Seenivasan, Thanalakshmi ; de Lemos, James A ; Jialal, Ishwarlal. / Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. In: American Journal of Clinical Nutrition. 2007 ; Vol. 86, No. 5. pp. 1392-1398.
@article{88a572c306224effb955c5f922b29607,
title = "Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease",
abstract = "Background: Oxidative stress and inflammation are crucial in atherogenesis. α-Tocopherol is both an antioxidant and an antiinflammatory agent. Objective: We evaluated the effect of RRR-α-tocopherol supplementation on carotid atherosclerosis in patients with stable coronary artery disease (CAD) on drug therapy. Design: Randomized, controlled, double-blind trial compared RRR-α-tocopherol (1200 IU/d for 2 y) with placebo in 90 patients with CAD. Intimal medial thickness (IMT) of both carotid arteries was measured by high-resolution B-mode ultrasonography at 0, 1, 1.5, and 2 y. At 6-mo intervals, plasma α-tocopherol concentrations, C-reactive protein (CRP), LDL oxidation, monocyte function (superoxide anion release, cytokine release, and adhesion to endothelium), and urinary F2-isoprostanes were measured. Results: α-Tocopherol concentrations were significantly higher in the α-tocopherol group but not in the placebo group. High-sensitivity CRP concentrations were significantly lowered with α-tocopherol supplementation than with placebo (32{\%}; P < 0.001). α-Tocopherol supplementation significantly reduced urinary F2-isoprostanes (P < 0.001) and monocyte superoxide anion and tumor necrosis factor release compared with baseline and placebo (P < 0.001). No significant difference was observed in the mean change in total carotid IMT in the placebo and α-tocopherol groups. In addition, no significant difference in cardiovascular events was observed (P = 0.21). Conclusions: High-dose RRR-α-tocopherol supplementation in patients with CAD was safe and significantly reduced plasma biomarkers of oxidative stress and inflammation but had no significant effect on carotid IMT during 2 y.",
keywords = "Atherosclerosis, Carotid, Coronary artery disease, Inflammation, Intimal media thickness, Oxidative stress, Vitamin E",
author = "Sridevi Devaraj and Rong Tang and Huet, {Beverley A} and Andrea Harris and Thanalakshmi Seenivasan and {de Lemos}, {James A} and Ishwarlal Jialal",
year = "2007",
month = "11",
day = "1",
language = "English (US)",
volume = "86",
pages = "1392--1398",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "5",

}

TY - JOUR

T1 - Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease

AU - Devaraj, Sridevi

AU - Tang, Rong

AU - Huet, Beverley A

AU - Harris, Andrea

AU - Seenivasan, Thanalakshmi

AU - de Lemos, James A

AU - Jialal, Ishwarlal

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Background: Oxidative stress and inflammation are crucial in atherogenesis. α-Tocopherol is both an antioxidant and an antiinflammatory agent. Objective: We evaluated the effect of RRR-α-tocopherol supplementation on carotid atherosclerosis in patients with stable coronary artery disease (CAD) on drug therapy. Design: Randomized, controlled, double-blind trial compared RRR-α-tocopherol (1200 IU/d for 2 y) with placebo in 90 patients with CAD. Intimal medial thickness (IMT) of both carotid arteries was measured by high-resolution B-mode ultrasonography at 0, 1, 1.5, and 2 y. At 6-mo intervals, plasma α-tocopherol concentrations, C-reactive protein (CRP), LDL oxidation, monocyte function (superoxide anion release, cytokine release, and adhesion to endothelium), and urinary F2-isoprostanes were measured. Results: α-Tocopherol concentrations were significantly higher in the α-tocopherol group but not in the placebo group. High-sensitivity CRP concentrations were significantly lowered with α-tocopherol supplementation than with placebo (32%; P < 0.001). α-Tocopherol supplementation significantly reduced urinary F2-isoprostanes (P < 0.001) and monocyte superoxide anion and tumor necrosis factor release compared with baseline and placebo (P < 0.001). No significant difference was observed in the mean change in total carotid IMT in the placebo and α-tocopherol groups. In addition, no significant difference in cardiovascular events was observed (P = 0.21). Conclusions: High-dose RRR-α-tocopherol supplementation in patients with CAD was safe and significantly reduced plasma biomarkers of oxidative stress and inflammation but had no significant effect on carotid IMT during 2 y.

AB - Background: Oxidative stress and inflammation are crucial in atherogenesis. α-Tocopherol is both an antioxidant and an antiinflammatory agent. Objective: We evaluated the effect of RRR-α-tocopherol supplementation on carotid atherosclerosis in patients with stable coronary artery disease (CAD) on drug therapy. Design: Randomized, controlled, double-blind trial compared RRR-α-tocopherol (1200 IU/d for 2 y) with placebo in 90 patients with CAD. Intimal medial thickness (IMT) of both carotid arteries was measured by high-resolution B-mode ultrasonography at 0, 1, 1.5, and 2 y. At 6-mo intervals, plasma α-tocopherol concentrations, C-reactive protein (CRP), LDL oxidation, monocyte function (superoxide anion release, cytokine release, and adhesion to endothelium), and urinary F2-isoprostanes were measured. Results: α-Tocopherol concentrations were significantly higher in the α-tocopherol group but not in the placebo group. High-sensitivity CRP concentrations were significantly lowered with α-tocopherol supplementation than with placebo (32%; P < 0.001). α-Tocopherol supplementation significantly reduced urinary F2-isoprostanes (P < 0.001) and monocyte superoxide anion and tumor necrosis factor release compared with baseline and placebo (P < 0.001). No significant difference was observed in the mean change in total carotid IMT in the placebo and α-tocopherol groups. In addition, no significant difference in cardiovascular events was observed (P = 0.21). Conclusions: High-dose RRR-α-tocopherol supplementation in patients with CAD was safe and significantly reduced plasma biomarkers of oxidative stress and inflammation but had no significant effect on carotid IMT during 2 y.

KW - Atherosclerosis

KW - Carotid

KW - Coronary artery disease

KW - Inflammation

KW - Intimal media thickness

KW - Oxidative stress

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=36249001810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36249001810&partnerID=8YFLogxK

M3 - Article

C2 - 17991651

AN - SCOPUS:36249001810

VL - 86

SP - 1392

EP - 1398

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 5

ER -